Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation

van der Houwen LE, Lisette E E van der Houwen, Velja Mijatovic, Elmer Leemhuis, Leemhuis E, R. Schats, Schats R, Roel Schats, Martijn W. Heymans, Cornelis B. Lambalk, Peter G A Hompes, Hompes PG
Reproductive BioMedicine Online · 2013 · vol. 28(1) , pp. 39–46 · doi:10.1016/j.rbmo.2013.09.027 · PMID:24262434 · W2077305150
Observational OA: bronze CC0 ⤵ 33 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated the effectiveness and safety of IVF/ICSI treatments in women with severe endometriosis following extended pituitary down-regulation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Long-term pituitary down-regulation with a gonadotrophin-releasing hormone (GnRH) agonist for 3–6 months prior to IVF/intracytoplasmic sperm injection (ICSI) improves clinical pregnancy rates in endometriosis patients. However, some discussion about this treatment strategy still exists. This retrospective study from a tertiary-care university hospital examined the efficacy and safety of IVF/ICSI with and without long-term pituitary down-regulation in severe endometriosis patients (surgically confirmed American Society for Reproductive Medicine stages III and IV). All first IVF/ICSI treatment cycles between January 2009 and January 2012 were analysed. In patients treated with (n = 68) and without (n = 45) long-term pituitary down-regulation, 13 (19.1%) versus nine (20.0%) ongoing pregnancies after fresh embryo transfer (adjusted OR 0.58, 95% CI 0.18–1.86,) and 24 (35.3%) versus 10 (22.2%) ongoing pregnancies after fresh and cryopreserved embryo transfers (adjusted OR 1.62, 95% CI 0.60–4.38) were accomplished, respectively. Three complications (2.7%) and three recurrences (2.7%) were reported, only in patients treated with long-term pituitary down-regulation. The 1-year cumulative endometriosis recurrence rate was 7.3%. IVF/ICSI in patients with severe endometriosis is safe with low complication and recurrence rates. A favourable effect, albeit non-significant, of long-term pituitary down-regulation in achieving an ongoing pregnancy was observed only after including cryopreserved embryo transfers.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Down-Regulation Down-Regulation Endometriosis Fertilization in Vitro Gonadotropin-Releasing Hormone Leuprolide Pituitary Gland Sperm Injections, Intracytoplasmic Endometriosis Endometriosis Female Female Fertilization in Vitro Fertilization in Vitro Fertilization in Vitro Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Humans Leuprolide

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (37)

Cited by (31)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:12:56.342978+00:00
License: CC0 · commercial use OK